MBX Biosciences, Inc.
- Stock
- Ticker MBX
- Nasdaq
Performance, volatility and drawdowns of MBX Biosciences, Inc. since 09/2024, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $22,564. Global equities (VT): $10,273.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −77.7% in 04/2025, measured from the peak in 09/2024. It took 14 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -19 | -27 | -22 | -24 | -26 | -27 | -41 | -66 |
| EBITDA | -19 | -26 | -22 | -24 | -26 | -27 | -41 | -66 |
| Net income | -16 | -24 | -19 | -22 | -22 | -24 | -37 | -62 |
| Earnings per share | 9.60 | -0.71 | -0.58 | -0.63 | -0.45 | -0.50 | -0.78 | -1.29 |
| Balance sheet | ||||||||
| Total assets | 269 | 246 | 232 | 400 | 385 | 453 | 436 | 501 |
| Liabilities | 11 | 11 | 12 | 13 | 16 | 15 | 26 | 28 |
| Equity | 257 | 235 | 219 | 388 | 369 | 438 | 410 | 473 |
| Cash | 49 | 30 | 40 | 223 | 75 | 45 | 54 | 162 |
| Cash flow | ||||||||
| Operating cash flow | -16 | -23 | -17 | -22 | -18 | -20 | -23 | -35 |
| Capital expenditure | -0.1 | 0.0 | -0.7 | -0.4 | -0.8 | -0.4 | -0.9 | -1.2 |
| Free cash flow | -16 | -23 | -18 | -22 | -19 | -21 | -24 | -36 |
Value it:DCF calculatorMultiples calculator
Annual returns
* partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 9 Nov 2026 | −$1.29 |
| 6 Aug 2026 | −$0.78 |
| 7 May 2026 | −$0.50 |
| 12 Mar 2026 | −$0.45 |
| 6 Nov 2025 | −$0.63 |
| 7 Aug 2025 | −$0.58 |
| 12 May 2025 | −$0.71 |
| 17 Mar 2025 | $9.60 |
| 7 Nov 2024 | −$7.68 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €2.2bn
- Market cap in trading currency
- $2.46bn
- Enterprise value
- $1.98bn
- P/E
- –
- P/S
- –
- P/B
- 5.20
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -4.0%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$160m
- Net income
- −$145m
- Earnings per share
- −$3.02
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -33.7%
- Return on assets
- -29.0%
Balance sheet and cash flow
- Cash
- $482m
- Cash per share
- $9.70
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 19.58
- Book value per share
- $9.52
- Operating cash flow
- −$96.0m
- Free cash flow
- −$99.3m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 49.7m
- Volume
- 581,887
- Avg. volume 3 months
- 528,714
- Relative volume
- 1.1
Price and technicals
- Price
- $49.55
- 1 day
- −7.2%
- 52-week high
- $70.70
- 52-week low
- $26.92
- Distance to 52-week high
- −29.9%
- Distance to 52-week low
- +84.1%
- Distance to 50-day line
- −9.7%
- Distance to 200-day line
- +6.1%
- RSI (14)
- 41
- Volatility 1M
- 67.9%
Performance
- 1 week
- −11.4%
- 1 month
- −1.8%
- 3 months
- −25.4%
- 6 months
- +55.6%
- YTD
- +57.1%
- 1 year
- +80.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has MBX performed since 09/2024?
$10,000 grew to $20,951 by 20 Nov 2026, which is +40.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is MBX?
Volatility was 87.4% per year, measured on monthly returns. The largest decline from a peak was −77.7%, with the low in 04/2025.
How does MBX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.4% per year at 13.2% volatility, MBX returned +40.3% at 87.4%. The correlation of monthly returns was 0.11; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.